Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by Janssen Sciences Ireland UC .
Filed returns
17
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| Jan–Apr 2026 | Janssen Sciences Ireland UC | EU Affairs | Meeting to discuss EU Presidency Plans (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2026 | Janssen Sciences Ireland UC | EU Affairs | Meeting with Irish Perm Rep on Critical Medicines policy (Legislation) | 1 | On lobbying.ie |
| Jan–Apr 2026 | Janssen Sciences Ireland UC | Health | Meetings with Government Ministers, parliamentarians, and officials with the US Chamber of Commerce delegation in February 2026 (Public policy or programme) | 7 | On lobbying.ie |
| Sep–Dec 2025 | Janssen Sciences Ireland UC | EU Affairs | Meeting with Maeve von Heynitz (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2025 | Janssen Sciences Ireland UC | Economic Development and Industry | Meeting with Minister of State Thomas Byrne (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2025 | Janssen Sciences Ireland UC | Economic Development and Industry | Engagement with the Tánaiste (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2025 | Janssen Sciences Ireland UC | Economic Development and Industry | Meeting with Minister Thomas Byrne on EU Presidency priorities (Public policy or programme) | 2 | On lobbying.ie |
| May–Aug 2025 | Janssen Sciences Ireland UC | Health | Engagement with Tánaiste Simon Harris (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2025 | Janssen Sciences Ireland UC | Health | Industry meeting with Tánaiste on biopharmaceutical policy priorities (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2025 | Janssen Sciences Ireland UC | Economic Development and Industry | Introductions to new Ministers outlining industry priorities (Public policy or programme) | 3 | On lobbying.ie |
| Sep–Dec 2024 | Janssen Sciences Ireland UC | Health | Engagement with Oireachtas members re new development funding for medicines due for reimbursement in 2025. (Matters involving public funds) | 3 | On lobbying.ie |
| Sep–Dec 2023 | Janssen Sciences Ireland UC | Budgetary matters | Engagement with Government Ministers about Budget 2024 (Matters involving public funds) | 9 | On lobbying.ie |
| Jan–Apr 2023 | Janssen Sciences Ireland UC | Health | Discussion at IPHA Conference on Life Sciences Policy for Ireland (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2021 | Janssen Sciences Ireland UC | Health | Sharing information on European Beating Cancer Plan and impact on Ireland (Public policy or programme) | 10 | On lobbying.ie |
| Jan–Apr 2020 | Janssen Sciences Ireland UC | Economic Development and Industry | Briefing on business continuity plans during COVID-19 pandemic and progress on vaccine development as well as offering to support health service with expertise and capabilities (Public policy or programme) | 4 | On lobbying.ie |
| Sep–Dec 2019 | Janssen Sciences Ireland UC | Public Expenditure and Reform | Site visit to Janssen Bio2 and discussed how State can continue to support and collaborate with life sciences sector (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2019 | Janssen Sciences Ireland UC | Health | Impact of Brexit on the Life Sciences Sector (Public policy or programme) | 1 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 7 | 41.2% | |
| Economic Development and Industry | 5 | 29.4% | |
| EU Affairs | 3 | 17.6% | |
| Budgetary matters | 1 | 5.9% | |
| Public Expenditure and Reform | 1 | 5.9% |